vrs37 is a liar and manipulator or just dumb - probably both.
The citing of this article is manipulative and irrelevant. The focus of the article is on tolerance caused inefficacy and uses examples where the tolerance - and resulting inefficacy - manifested after 2 to 4 days.
This is totally irrelevant to DMX-200 given that the Phase 2a trial was over 16 weeks and therefore accommodated, well, any 'toleration' effect that may have occurred.
Dimerix (ASX: DXB) Discussion Thread, page-427
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
-0.005(1.23%) |
Mkt cap ! $222.9M | |||
| Open | High | Low | Value | Volume |
| 42.5¢ | 43.0¢ | 39.8¢ | $436.4K | 1.067M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 24999 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 41.0¢ | 11224 | 1 |
View Market Depth
| Last trade - 16.10pm 31/10/2024 (20 minute delay) ? |
| DXB (ASX) Chart |